Sort
51,593 grants matching “hepatitis”
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
$620,810Michael H Nathanson · Yale University · R01 · FY2024 · AA
Hyperhomocysteinemia and HDL Metabolism
$620,768Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2016 · HL
Hyperhomocysteinemia and HDL Metabolism
$620,768Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2017 · HL
Dendritic cell-based vaccination against hepatitis C
$620,745Stephen H. Gregory · University Of Rhode Island · U19 · FY2011 · AI
Evaluation of a community-based education, navigation, and support (CENS) intervention to reduce opioid-related harms among military veterans
$620,729Alexander S Bennett · New York University · R01 · FY2025 · DA
Preservation of DCD Allograft Integrity for Liver Transplantation
$620,680Sylvester M Black · Ohio State University · R01 · FY2023 · DK
Preservation of DCD Allograft Integrity for Liver Transplantation
$620,680Sylvester M Black · Ohio State University · R01 · FY2021 · DK
Preservation of DCD Allograft Integrity for Liver Transplantation
$620,680Sylvester M Black · Ohio State University · R01 · FY2022 · DK
Prevention of Pediatric NAFLD in Hispanic Children
$620,659Miriam B. Vos · Emory University · R01 · FY2021 · NR
Reducing morbidity and mortality from overdose, HIV, and hepatitis C in opioid-using persons
$620,560Ronald Scott Braithwaite · New York University School Of Medicine · R01 · FY2022 · DA
The National Drug Abuse Treatment Clinical Trials Network
$620,499Walter Nmn Ling · University Of California Los Angeles · U10 · FY2011 · DA
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV
$620,489Robert A Schnoll · University Of Pennsylvania · R01 · FY2021 · CA
Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis
$620,487Keith D Robertson · Mayo Clinic Rochester · R01 · FY2017 · DK
Early-Stage Chronic Kidney Disease in HIV-infected Individuals
$620,459Gregory M Lucas · Johns Hopkins University · R01 · FY2017 · DA
PCB-mediated dysbiosis of the gut microbiome: A missing link in PCB-mediated neurodevelopmental disorders?
$620,458Hans-Joachim Lehmler · University Of Iowa · R01 · FY2022 · ES
Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes
$620,404Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATION
$620,284University Of Michigan At Ann Arbor · U01 · FY2001 · DK
Regulation of hippocampal function by central and peripheral IRS signaling
$620,229Morris F. White · Boston Children'S Hospital · R01 · FY2024 · AG
Regulation of hippocampal function by central and peripheral IRS signaling
$620,229Morris F. White · Boston Children'S Hospital · R01 · FY2021 · AG
Regulation of hippocampal function by central and peripheral IRS signaling
$620,229Morris F. White · Boston Children'S Hospital · R01 · FY2023 · AG
Regulation of hippocampal function by central and peripheral IRS signaling
$620,229Morris F. White · Boston Children'S Hospital · R01 · FY2022 · AG
Regulation of hippocampal function by central and peripheral IRS signaling
$620,229Morris F. White · Boston Children'S Hospital · R01 · FY2020 · AG
Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)
$620,205Manal M Hassan · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Hereditary Genetics of Hepatocellular Carcinoma
$620,136Kirk J Wangensteen · Mayo Clinic Rochester · R37 · FY2025 · CA
ANALYSIS OF CHEMICAL STRUCTURES AND THERAPEUTIC ACTIVITY OF AGENTS FOR HIV AND TUBERCULOSIS (CHEMDB)
$620,111Louise Sumner · Gryphon Scientific, Llc · N01 · FY2019 · AI